Tick-Borne Diseases: Recognized and Theorectical Risks Associated with Blood Transfusion

  • David A. Leiby
  • Jennifer H. McQuiston
  • Rodger Y. Dodd
Part of the Developments in Hematology and Immunology book series (DIHI, volume 37)


Pathogenic microorganisms transmitted by ticks have taken on expanded public health significance during the last several decades. Ticks are now recognized to transmit over a dozen diseases that are caused by a variety of pathogenic agents ranging from bacteria and protozoa to viruses [1]. Humans have increasingly come in contact with ticks as they expand their outdoor recreational activities and move their homes to rural environments. Similarly, the reforestation of suburban neighborhoods has provided ideal habitats for transport and reservoir hosts (e.g., deer, rodents) of ticks and tick-borne diseases, further facilitating transmission to humans. During the same period, new etiologic agents of disease transmitted by ticks have emerged, while the geographic distribution of existing agents has expanded. Taken together, newly emergent tick-borne agents and those described previously pose an ongoing concern to public health.


Lyme Disease Scrub Typhus Blood Safety Rocky Mountain Spotted Fever Pathogen Inactivation 
These keywords were added by machine and not by the authors. This process is experimental and the keywords may be updated as the learning algorithm improves.


Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.


  1. 1.
    Spach DH, Liles WC, Campbell GL, Quick RE, Anderson DE, Fritsche TR. Tick-borne diseases in the United States. N Engl J Med 1993; 329: 936–47.PubMedCrossRefGoogle Scholar
  2. 2.
    McQuiston JH, Childs JE, Chamberland ME, et al. Transmission of tick-borne agents of disease by blood transfusion: a review of known and potential risks in the United States. Transfusion 2000; 40: 274–84.PubMedCrossRefGoogle Scholar
  3. 3.
    Cable RG, Trouern-Trend J. Tickborne infections. In: Linden JV, Bianco C, eds. Blood Safety and Surveillance. New York: Marcel Dekker, 2001: 399–422.Google Scholar
  4. 4.
    Saito-Ito A, Tsuji M, Wei Q, et al. Transfusion-acquired, autochthonous human babesiosis in Japan: isolation of Babesia microti-like parasites with hu-RBC-SCID mice. J Clin Microbiol 2000; 38: 4511–16.PubMedGoogle Scholar
  5. 5.
    Fritz C, Hui L, Kjemtrup A, Thompson M. Tick-borne disease surveillance. In: 2000 Annual Report, Vector-Borne Disease Section, California Department of Health Services:20–22.Google Scholar
  6. 6.
    Eastlund T, Persing D, Mathiesen D, et al. Human granulocytic ehrlichiosis after red cell transfusion. Transfusion 1999; 39 (Suppl): 117S.Google Scholar
  7. 7.
    Scholtens RG, Braff EH, Healy GR, Gleason N. A case of babesiosis in man in the United States. Am J Trop Med Hyg 1968; 17: 810–13.PubMedGoogle Scholar
  8. 8.
    Quick RE, Herwaldt BL, Thomford JW, et al. Babesiosis in Washington State: A new species of Babesia? Ann Intern Med 1993; 119: 284–90.Google Scholar
  9. 9.
    Herwaldt BL, Persing DH, Précigout EA, et al. A fatal case of babesiosis in Missouri: Identification of another piroplasm that infects humans. Ann Intern Med 1996; 124: 643–50.PubMedGoogle Scholar
  10. 10.
    Kjemtrup AM, Conrad PA. Human babesiosis: an emerging tick-borne disease. Int J Parasitol. 2000; 30: 1323–37.PubMedCrossRefGoogle Scholar
  11. 11.
    White DJ, Talarico J, Chang H, et al. Human babesiosis in New York state. Review of 139 hospitalized cases and analysis of prognostic factors. Arch Intern Med 1998; 158: 2149–54.PubMedCrossRefGoogle Scholar
  12. 12.
    Quick RE, Herwaldt BL, Thomford JW, et al. Babesiosis in Washington State: A new species of Babesia? Ann Intern Med 1993; 119: 284–90.Google Scholar
  13. 13.
    Popovsky MA, Lindberg LE, Syrek AL, Page PL. Prevalence of Babesia antibody in a selected blood donor population. Transfusion 1988; 28: 59–61.PubMedCrossRefGoogle Scholar
  14. 14.
    Linden JV, Wong SJ, Chu FK, Schmidt GB, Bianco C. Transfusion-associated transmission of babesiosis in New York State. Transfusion 2000; 40: 285–89.PubMedCrossRefGoogle Scholar
  15. 15.
    McKechnie DB, Slater KS, Childs JE, et al. Survival of Ehrlichia chaffeensis in refrigerated, ADSOL-treated RBCs. Transfusion 2000; 40: 1041–47.PubMedCrossRefGoogle Scholar
  16. 16.
    Kalantarpour F, Chowdhury I, Wormser GP, et al: Survival of the human granulocytic ehrlichiosis agent under refrigeration conditions. J Clin Micro biol 2000; 38: 2398–99.Google Scholar
  17. 17.
    Wells GM, Woodward TE, Fiset P, Hornick RB. Rocky Mountain spotted fever caused by blood transfusion. JAMA 1978; 239: 2763–65.PubMedCrossRefGoogle Scholar
  18. 18.
    Randall WH, Simmons J, Casper EA, Philip RN. Transmission of Colorado tick fever virus by blood transfusion - Montana. MMWR 1975; 24: 422, 427.Google Scholar
  19. 19.
    Wahlberg P, Saikku P, Brummer-Korvenkontio M. Tick-borne viral encephalitis in Finland. The clinical features of Kumlinge disease during 19591987. J Int Med 1989; 225: 173–77.CrossRefGoogle Scholar
  20. 20.
    Cable R, Krause P, Badon S, Silver H, Ryan R. Acute blood donor co-infection with Babesia microti (Bm) and Borrelia burgdorferi (Bb). Transfusion 1993; 33 (Suppl.): 505.Google Scholar
  21. 21.
    Johnson SE, Swaminathan B, Moore P, Broome CV, Parvin M. Borrelia burgdorferi: survival in experimentally infected human blood processed for transfusion. J Infect Dis 1990; 162: 557–59.PubMedCrossRefGoogle Scholar
  22. 22.
    Shrestha M, Grodzicki RL, Steere AC. Diagnosing early Lyme disease. Am J Med 1985; 78: 235–40.PubMedCrossRefGoogle Scholar
  23. 23.
    Mather TN, Telford SR, Moore SI, Spielman A Borrelia burgdorferi and Babesia microti: efficiency of transmission from reservoirs to vector ticks (Ixodes dammini). Exp Parasitol 1990; 70: 55–61.PubMedCrossRefGoogle Scholar
  24. 24.
    Mettille FC, Salata KF, Belanger KJ, Casleton BG, Kelly DJ. Reducing the risk of transfusion-transmitted rickettsial disease by WBC filtration, using Orientia tsutsugamushi in a model system. Transfusion 2000; 40: 290–96.PubMedCrossRefGoogle Scholar
  25. 25.
    Grellier P, Santus R, Louray E., et al. Photosensitized inactivation of Plasmodium falciparum-and Babesia divergens-infected erythrocytes in whole blood by lipophilic pheophorbide derivatives. Vox Sang 1997; 72: 211–20.PubMedCrossRefGoogle Scholar

Copyright information

© Springer Science+Business Media Dordrecht 2002

Authors and Affiliations

  • David A. Leiby
    • 1
  • Jennifer H. McQuiston
    • 2
  • Rodger Y. Dodd
    • 1
  1. 1.Transmissible Diseases DepartmentAmerican Red Cross Jerome Holland LaboratoryRockvilleUSA
  2. 2.National Center for Infectious DiseasesCenters for Disease Control and PreventionAtlantaUSA

Personalised recommendations